Plunkett Research Online: HUTCHMED (China) Ltd

HUTCHMED (CHINA) LTD (HCM:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Its reportable segments include the innovation platform and commercial.....



HUTCHMED (China) Ltd
Ticker: HCM
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 852 21218200
Fax: 852 21281778
Address: 2 Queen's Road Central
48th Floor, Cheung Kong Center
Hong Kong, Hong Kong

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drug Manufacturers - Major

Ranks not available
Contacts Description
Weiguo SuCEO/Chief Scientific Officer/Director
Johnny FungCFO/Director
See More
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Its reportable segments include the innovation platform and commercial.....See More See More

Auditor: PricewaterhouseCoopers Zhong Tian LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202320222021202020192018
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: